2025 annual financial data
Aprea Therapeutics 2025 Net margin
Direct answer
Net margin was -4,409.16%.
Operating income was -13,233,836 USD and net income was -12,599,569 USD.
Operating cash flow was -12,894,439 USD.
Get free Aprea Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 285,759 USD
- Operating income
- -13,233,836 USD
- Net income
- -12,599,569 USD
- Operating cash flow
- -12,894,439 USD